Abstract
In the originally published version of this article, the author name Royce P. Vincent was incorrectly listed as Vincent P. Royce.The publisher would like to apologise for any inconvenience caused. In the originally published version of this article, the author name Royce P. Vincent was incorrectly listed as Vincent P. Royce. The publisher would like to apologise for any inconvenience caused. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgerySurgery for Obesity and Related DiseasesVol. 10Issue 5PreviewRoux-en-Y gastric bypass (RYGB) surgery is an effective and frequently used surgical treatment for severe obesity. Postoperative weight loss varies markedly, but biomarkers to predict weight loss outcomes remain elusive. Levels of the satiety gut hormones glucagon like peptide-1 (GLP-1) and peptide YY (PYY) are attenuated in obese patients but elevated after RYGB surgery. We aimed to evaluate the preoperative responses of GLP-1 and PYY to a standard meal as a predictor of weight loss after RYGB surgery. Full-Text PDF
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
